Top Markets
Coin of the day
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Rang în acțiuni #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Preț acțiune
$0.49606484
Ultima sincronizare: 2026-08-21
Capitalizare de piață
$88.47M
Schimbare (1 zi)
-1.58%
Schimbare (1 an)
-22.51%
Țară
TW
Tranzacționează Intech Biopharm Corporation (6461)

Categorie

Raport P/S pentru Intech Biopharm Corporation (6461)
Raport P/S la data de 2026 TTM: 0
Conform celor mai recente rapoarte financiare și prețului acțiunilor Intech Biopharm Corporation, raportul P/S actual (TTM) este 0. La sfârșitul anului 2026, compania avea un P/S de 0.
Istoricul raportului P/S pentru Intech Biopharm Corporation din 2026 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
Nu sunt suficiente date pentru perioada selectată.
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
10.17 -
US
10.13 -
NL
11.28 -
US
2.95 -
AU
- -
CH